Expression of γ-H2AX in melanocytic lesions

Human Pathology

Volumn 39, Issue 11, 2008, Pages 1614-1620

  Wasco, Matthew J ^a   Pu, Robert T ^a   Yu, Limin ^a   Su, Lyndon ^a   Ma, Linglei ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

H2AX; Melanoma in situ; Metastatic melanoma; Nevus; Primary melanoma

Indexed keywords

HISTONE ANTIBODY; HISTONE GAMMA H2AX; HISTONE H2AX; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; DYSPLASTIC NEVUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOMA; MITOSIS RATE; PROGNOSIS; PROTEIN EXPRESSION; SENTINEL LYMPH NODE;

DYSPLASTIC NEVUS SYNDROME; FEMALE; GENE EXPRESSION; HISTONES; HUMANS; MALE; MELANOMA; NEVUS; NEVUS, EPITHELIOID AND SPINDLE CELL; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 53849102172     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.03.007     Document Type: Article

References (28)

1. Houghton A.N., and Polsky D. Focus on melanoma. Cancer Cell 2 (2002) 275-278
2. Soengas M.S., and Lowe S.W. Apoptosis and melanoma chemoresistance. Oncogene 22 (2003) 3138-3151
3. Clark W.H., Elder D.E., Guerry D., Epstein M.N., Greene M.H., and Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 15 (1984) 1147-1165
4. Molho-Pessach V., and Lotem M. Ultraviolet radiation and cutaneous carcinogenesis. Curr Probl Dermatol 35 (2007) 14-27
5. Bartkova J., Horejsi Z., Koek K., et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005) 864-870
6. Warters R.L., Adamson P.J., Pond C.D., and Leachman S.A. Melanoma cells express elevated levels of phosphorylated histone H2AX foci. J Invest Dermatol 124 (2005) 807-817
7. Bakkenist C.J., and Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (2003) 499-506
8. Hanasoge S., and Ljungman M. H2AX phosphorylation after UV-irradiation is triggered by DNA repair intermediates and is mediated by the ATR kinase. Carcinogenesis 28 (2007) 2298-2304
9. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., and Bonner W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10 (2000) 886-895
10. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 (2005) 907-913
11. Wasco MJ, Pu RT. Utility of anti-phosphorylated H2AX antibody in diagnosing metastatic renal cell carcinoma. Appl Immunohistochem Mol Morphol [in press].
12. Pozo L., Naase M., Cerio R., Blanes A., and Diaz-Cano S.J. Critical analysis of histologic criteria for grading atypical (dysplastic) melanocytic nevi. Am J Clin Pathol 115 (2001) 194-204
13. Reed J.A., Loganzo F., Shea C.R., et al. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res 55 (1995) 2713-2718
14. Lassam N.J., From L., and Kahn H.J. Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res 53 (1993) 2235-2238
15. Korabiowska M., Brinck U., Hoenig J.F., et al. Significance of p53 antigen in malignant melanomas and naevi of the head and neck area. Anticancer Res 15 (1995) 885-889
16. Zhang Y., Cho Y., Petersen B.L., Bode A.M., Zhu F., and Dong Z. Ataxia telangiectasia mutated proteins, MAPKs, and RSK2 are involved in the phosphorylation of STAT3. J Biol Chem 278 (2003) 12650-12659
17. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC Cancer Staging Manual. 6th ed (2003), Springer, London (UK)
18. Lukas C., Falck J., Bartkova J., Batrek J., and Lukas J. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nat Cell Biol 5 (2003) 255-260
19. Ekholm-Reed S., Mendez J., Tedesco D., Zetterberg A., Stillman B., and Reed S.I. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J Cell Biol 165 (2004) 789-800
20. Ward I.M., Minn K., and Chen J. UV-induced ataxia-telangiectasia-mutated and Rad3-related (ATR) activation requires replication stress. J Biol Chem 279 (2004) 9677-9680
21. Halicka H.D., Huang X., Traganos F., King M.A., Dai W., and Darzynkiewicz Z. Histone H2AX phosphorylation after cell irradiation with UV-B: relationship to cell cycle phase and induction of apoptosis. Cell Cycle 4 (2005) 339-345
22. Marti T.M., Hefner E., Feeney L., Natale V., and Cleaver J.E. H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double strand breaks. Proc Natl Acad Sci U S A 103 (2006) 9891-9896
23. Inohara S., Kitagawa K., and Kitano Y. Expression of cyclin D1 and p53 protein in various malignant skin tumors. Dermatology 192 (1996) 94-98
24. Busam K.J., Chen Y.T., Old L.J., et al. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol 22 (1998) 976-982
25. Blessing K., Sanders D.S., and Grant J.J. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 32 (1998) 139-146
26. Su L.D., Fullen D.R., Lowe L., et al. Desmoplastic and neurotropic melanoma. Cancer 100 (2004) 598-604
27. Livestro D.P., Muzikanski A., Kaine E.M., et al. Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol 23 (2005) 6739-6746
28. Munshi A., Kurland J.F., Nishikawa T., et al. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res 11 (2005) 4912-4922